Skip to main content
Clinical Trials/NCT00500695
NCT00500695
Completed
Phase 1

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Rutgers, The State University of New Jersey1 site in 1 country98 target enrollmentMay 2006

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Rutgers, The State University of New Jersey
Enrollment
98
Locations
1
Primary Endpoint
Attendance at first smoking cessation session
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This project will assess the utility of a brief motivational intervention to engage smokers with schizophrenia in treatment for tobacco dependence treatment. It is hypothesized that a brief motivational intervention will be more effective in engaging smokers with schizophrenia to tobacco dependence treatment than an educational intervention. The educational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by teaching subjects about the negative effects of smoking and the success of tobacco dependence treatment. The motivational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by increasing subjects' motivation to change by presenting objective and personalized information regarding their smoking behaviors in a non-judgmental and supportive manner.

Detailed Description

See Brief Summary above.

Registry
clinicaltrials.gov
Start Date
May 2006
End Date
October 2013
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marc L. Steinberg, Ph.D.

Associate Professor

Rutgers, The State University of New Jersey

Eligibility Criteria

Inclusion Criteria

  • Current smokers must be over the age of 18,
  • Must have a diagnosis of schizophrenia or schizoaffective disorder
  • Must smoke at least 10 cigarettes per day
  • Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22

Exclusion Criteria

  • Those unable to give informed consent.

Outcomes

Primary Outcomes

Attendance at first smoking cessation session

Time Frame: one month

Secondary Outcomes

  • Cigarettes per day(1-Month Follow Up)

Study Sites (1)

Loading locations...

Similar Trials